These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 11426842)

  • 1. Effects of repeated GBR 12909 administration on brain stimulation reward.
    Melnick SM; Maldonado-Vlaar CS; Stellar JR; Trzcińska M
    Eur J Pharmacol; 2001 May; 419(2-3):199-205. PubMed ID: 11426842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of dopamine tone in the pursuit of brain stimulation reward.
    Hernandez G; Trujillo-Pisanty I; Cossette MP; Conover K; Shizgal P
    J Neurosci; 2012 Aug; 32(32):11032-41. PubMed ID: 22875936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine.
    Romualdi P; D'Addario C; Ferri S; Cox BM; Izenwasser S
    Eur J Pharmacol; 2001 Feb; 413(2-3):207-12. PubMed ID: 11226394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cocaine and GBR-12909 on brain stimulation reward.
    Maldonado-Irizarry CS; Stellar JR; Kelley AE
    Pharmacol Biochem Behav; 1994 Aug; 48(4):915-20. PubMed ID: 7972296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
    Matecka D; Rothman RB; Radesca L; de Costa BR; Dersch CM; Partilla JS; Pert A; Glowa JR; Wojnicki FH; Rice KC
    J Med Chem; 1996 Nov; 39(24):4704-16. PubMed ID: 8941383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.
    Matecka D; Lewis D; Rothman RB; Dersch CM; Wojnicki FH; Glowa JR; DeVries AC; Pert A; Rice KC
    J Med Chem; 1997 Feb; 40(5):705-16. PubMed ID: 9057857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine.
    Acri JB; Siedleck BK; Witkin JM
    J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of GBR 12909, a selective dopamine uptake inhibitor, on motor activity and operant behavior in the rat.
    Kelley AE; Lang CG
    Eur J Pharmacol; 1989 Aug; 167(3):385-95. PubMed ID: 2530095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate.
    Baumann MH; Ayestas MA; Sharpe LG; Lewis DB; Rice KC; Rothman RB
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1190-7. PubMed ID: 12023554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of alpha1-adrenergic receptors in acute and sensitized locomotor effects of D-amphetamine, cocaine, and GBR 12783: influence of preexposure conditions and pharmacological characteristics.
    Drouin C; Blanc G; Villégier AS; Glowinski J; Tassin JP
    Synapse; 2002 Jan; 43(1):51-61. PubMed ID: 11746733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.
    Desai RI; Kopajtic TA; French D; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 Oct; 315(1):397-404. PubMed ID: 16014753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesencephalic microinjections of neurotensin-(1-13) and its C-terminal fragment, neurotensin-(8-13), potentiate brain stimulation reward.
    Rompré PP; Gratton A
    Brain Res; 1993 Jul; 616(1-2):154-62. PubMed ID: 8358607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of cocaine with dopamine uptake inhibitors or dopamine releasers in rats discriminating cocaine.
    Li SM; Campbell BL; Katz JL
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1088-96. PubMed ID: 16478825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the discriminative-stimulus effects of GBR 12909.
    Melia KF; Spealman RD
    J Pharmacol Exp Ther; 1991 Aug; 258(2):626-32. PubMed ID: 1678014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of GBR 12909 on locomotor activity and dopamine turnover in mice: comparison with apomorphine.
    Irifune M; Nomoto M; Fukuda T
    Eur J Pharmacol; 1995 Jan; 272(1):79-85. PubMed ID: 7713153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral effects of rimcazole analogues alone and in combination with cocaine.
    Katz JL; Libby TA; Kopajtic T; Husbands SM; Newman AH
    Eur J Pharmacol; 2003 May; 468(2):109-19. PubMed ID: 12742518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence.
    Baumann MH; Phillips JM; Ayestas MA; Ali SF; Rice KC; Rothman RB
    Ann N Y Acad Sci; 2002 Jun; 965():92-108. PubMed ID: 12105088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of nicotine discrimination and discriminative stimulus effects of nicotine in rats chronically exposed to caffeine.
    Gasior M; Shoaib M; Yasar S; Jaszyna M; Goldberg SR
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1053-73. PubMed ID: 10027843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization to the rewarding effects of the specific dopamine uptake inhibitor GBR12783.
    Le Pen G; Duterte-Boucher D; Costentin J
    J Pharmacol Exp Ther; 1998 Aug; 286(2):688-96. PubMed ID: 9694922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GBR 12909 reverses the SCH 23390 inhibition of rewarding effects of brain stimulation.
    Rompré PP; Bauco P
    Eur J Pharmacol; 1990 Jun; 182(1):181-4. PubMed ID: 1976096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.